An analysis of effects on survival was done in LUSC to test if extreme high TrkB had a negative effect on outcomes in this tumor subtype, as TrkB protein levels are thought to be a negative predictor in a wide range of cancer types [10–16, 36]. The gene discussed is NTRK2; the disease is neoplasm.